Company intelligence / Profile preview

Delbert Pharma

Paris, Île-de-France, Francedelbertpharma.com ↗
Ownership
Private
Employees
~22
Development stage
Commercial
01

Overview

Delbert Pharma specializes in maintaining market access to essential medicines at risk of disappearing. The company has commercialized several mature drugs across infectiology, pulmonology, neurology/psychiatry, oncology and hematology. It has obtained approvals for antibiotics against staphylococcal infections and treatments for bipolar disorder relapse prevention. Some programs are preclinical or focused on rare disease repositioning. The company became a mission-driven entity in France in September 2023 to formalize its commitment to public health needs.

Therapeutic areas
PulmonologyOncologyPsychiatryNeurologyInfectious Diseases
Modalities
Small moleculesInjectable drugsBronchial fluidifiers
Industry
Biotech
02

Drug pipeline

3 assets

Xyllomac

Unknown

2 more assets in the full pipeline.

Request access →
03

Partnerships

Not explicitly listed; collaborates with French and European manufacturers and health authorities to safeguard medicine supply chains.

Beyond the preview

Go deeper on Delbert Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delbert Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call